Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma

被引：37
|
作者：
Dummer, Reinhard [1 ]
Guggenheim, Merlin [2 ]
Arnold, Andres W. [3 ]
Braun, Ralph [1 ]
von Moos, Roger [4 ]
机构：
[1] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Dept Surg, CH-8091 Zurich, Switzerland
[3] Unvers Hosp Basel, Dept Dermatol, Basel, Switzerland
[4] Kantonsspital Graubunden, Div Oncol, Graubunden, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2011年 / 141卷
关键词：
melanoma; guidelines; staging; therapy; follow-up; RANDOMIZED PHASE-III; SENTINEL-NODE BIOPSY; MALIGNANT-MELANOMA; RADIATION TREATMENT; TUMOR BURDEN; STAGE-III; SURVIVAL; DACARBAZINE; LYMPHADENECTOMY; BIOCHEMOTHERAPY;
D O I：
10.4414/smw.2011.13320
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Melanoma is the most common lethal cutaneous neoplasm. In order to harmonise treatment and follow-up of melanoma patients, guidelines for the management of melanoma in Switzerland were inaugurated in 2001 and revised in 2006. A new classification and recent results in randomised trials necessitated changes concerning staging and modifications of the recommendations of therapy and follow-up.
引用
收藏
页数：7
相关论文
共 50 条
  • [21] Effectiveness of clinical and instrumental follow-up for cutaneous melanoma
    Toia, Francesca
    Cajozzo, Marta
    Rosatti, Fernando
    Di Lorenzo, Sara
    Rinaldi, Gaetana
    Mazzucco, Walter
    Cordova, Adriana
    SURGICAL ONCOLOGY-OXFORD, 2022, 44
  • [22] Clinical and Imaging Follow-Up for High-Risk Cutaneous Melanoma: Current Evidence and Guidelines
    Vetto, John T.
    CANCERS, 2024, 16 (14)
  • [23] Follow-up in patients with localised primary cutaneous melanoma
    Francken, AB
    Bastiaannet, E
    Hoekstra, HJ
    LANCET ONCOLOGY, 2005, 6 (08): : 608 - 621
  • [24] Optimizing Follow-up Assessment of Patients with Cutaneous Melanoma
    Bhutiani, Neal
    Egger, Michael E.
    McMasters, Kelly M.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (04) : 861 - 863
  • [25] Optimizing Follow-up Assessment of Patients with Cutaneous Melanoma
    Neal Bhutiani
    Michael E. Egger
    Kelly M. McMasters
    Annals of Surgical Oncology, 2017, 24 : 861 - 863
  • [26] Follow-up of cutaneous melanoma patients: a proposal for standardization
    Moscarella, E.
    Ricci, C.
    Borgognoni, L.
    Bottoni, U.
    Catricala, C.
    Dika, E.
    Fanti, P. A.
    Landi, C.
    Manganoni, A. M.
    Pellacani, G.
    Peris, K.
    Pimpinelli, N.
    Quaglino, P.
    Richetta, A.
    Simonetti, V.
    Stanganelli, I.
    Testori, A.
    Zalaudek, I.
    Argenziano, G.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2014, 149 (06): : 633 - 638
  • [27] Prognostic significance of autoimmunity during adjuvant treatment of melanoma with interferon: Updated follow-up
    Dafni, U.
    Pectasides, D.
    Tsoutsos, D.
    Panagiotou, P.
    Polyzos, A.
    Stratigos, A.
    Markopoulos, C.
    Mantzourani, M.
    Bafaloukos, D.
    Gogas, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [28] A rational approach to melanoma follow-up in patients with primary cutaneous melanoma
    Dicker, TJ
    Kavanagh, GM
    Herd, RM
    Ahmad, T
    Mclaren, KM
    Chetty, U
    Hunter, JAA
    BRITISH JOURNAL OF DERMATOLOGY, 1999, 140 (02) : 249 - 254
  • [29] ASSESSING KNOWLEDGE AND ADHERENCE OF THE UPDATED COLONOSCOPY FOLLOW-UP GUIDELINES
    Ardolino, Eric
    Wang, Linda F.
    Dong, Jeffrey
    GASTROENTEROLOGY, 2022, 162 (07) : S1034 - S1034
  • [30] Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Willemze, R.
    Hodak, E.
    Zinzani, P. L.
    Specht, L.
    Ladetto, M.
    ANNALS OF ONCOLOGY, 2013, 24 : 149 - 154
12345